The Journal of allergy and clinical immunology
Journal
Overview
publication venue for
-
Accelerated cell-mediated immune reactions in penicillin allergy.
1993
-
Acquired deficiency of the inhibitor of the first component of complement: report of five additional cases with commentary on the syndrome.
1985
-
Vernix caseosa reveals mechanistic clues linking maternal obesity to atopic dermatitis pathogenesis..
153.
2023
-
Post-Transplant Late Complications Increase Over Time for Patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) Landmark Study.
2023
-
High plasma IL-6 levels may enhance the adverse effects of mouse allergen exposure in urban schools on asthma morbidity in children.
2023
-
Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis..
152.
2023
-
The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions..
151.
2022
-
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions..
151.
2022
-
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation..
151.
2022
-
Molecular and clinical effects of selective tyrosine kinase 2 inhibition with deucravacitinib in psoriasis.
2021
-
Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
2021
-
Genetic errors of immunity distinguish pediatric nonmalignant lymphoproliferative disorders..
149.
2021
-
Therapeutic options for CTLA-4 insufficiency..
149.
2021
-
High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
2021
-
Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets.
2021
-
Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa..
147.
2021
-
The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults..
148.
2021
-
Bone morphogenetic protein signaling regulates skin inflammation via modulating dendritic cell function..
147.
2020
-
Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities..
147.
2020
-
Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis..
147.
2020
-
Obesity may enhance the adverse effects of NO2 exposure in urban schools on asthma symptoms in children..
146.
2020
-
Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis..
145.
2020
-
Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis..
145.
2019
-
Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood..
145.
2019
-
Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus..
145.
2019
-
Cutaneous p38 mitogen-activated protein kinase activation triggers psoriatic dermatitis..
144.
2019
-
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis..
144.
2019
-
IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis..
144.
2019
-
The skin as an immune organ: Tolerance versus effector responses and applications to food allergy and hypersensitivity reactions..
144.
2019
-
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis..
144.
2019
-
Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab..
143.
2018
-
Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseases..
143.
2018
-
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis..
143.
2018
-
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab..
143.
2018
-
Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature..
143.
2018
-
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects..
142.
2018
-
Early-onset pediatric atopic dermatitis is characterized by TH2/TH17/TH22-centered inflammation and lipid alterations..
141.
2018
-
Enhancement of cutaneous immunity during aging by blocking p38 mitogen-activated protein (MAP) kinase-induced inflammation..
142.
2017
-
Staged development of long-lived T-cell receptor αβ TH17 resident memory T-cell population to Candida albicans after skin infection..
142.
2017
-
Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations..
141.
2017
-
Serum IgG and risk of exacerbations and hospitalizations in chronic obstructive pulmonary disease..
140.
2017
-
Basophil-derived IL-4 promotes epicutaneous antigen sensitization concomitant with the development of food allergy..
141.
2017
-
Regulated in development and DNA damage responses 1 (REDD1) links stress with IL-1β-mediated familial Mediterranean fever attack through autophagy-driven neutrophil extracellular traps..
140.
2017
-
Alterations in B-cell subsets in pediatric patients with early atopic dermatitis..
140.
2016
-
Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling..
139.
2016
-
An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis..
139.
2016
-
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders..
139.
2016
-
Anti-hIgE gene therapy of peanut-induced anaphylaxis in a humanized murine model of peanut allergy..
138.
2016
-
Staphylococcal serine protease-like proteins are pacemakers of allergic airway reactions to Staphylococcus aureus..
139.
2016
-
Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study..
137.
2016
-
A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis..
138.
2016
-
The tryptophan metabolism enzyme L-kynureninase is a novel inflammatory factor in psoriasis and other inflammatory diseases..
137.
2015
-
Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency..
137.
2015
-
Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis..
137.
2015
-
Petrolatum: Barrier repair and antimicrobial responses underlying this "inert" moisturizer..
137.
2015
-
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization..
136.
2015
-
Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing..
136.
2015
-
Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets..
136.
2015
-
RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications..
135.
2015
-
Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial..
136.
2015
-
Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population..
136.
2015
-
Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin..
135.
2015
-
Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection..
135.
2015
-
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis..
134.
2014
-
Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations..
134.
2014
-
Comparison of US emergency department acute asthma care quality: 1997-2001 and 2011-2012..
135.
2014
-
Dry roasting enhances peanut-induced allergic sensitization across mucosal and cutaneous routes in mice..
134.
2014
-
Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals..
134.
2014
-
Clinical features and resolution of food protein-induced enterocolitis syndrome: 10-year experience..
134.
2014
-
Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology..
133.
2014
-
Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response..
134.
2014
-
Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis..
133.
2014
-
Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis..
133.
2014
-
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience..
133.
2013
-
Primary Immune Deficiency Treatment Consortium (PIDTC) report..
133.
2013
-
Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis..
132.
2013
-
Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis..
130.
2012
-
IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis..
130.
2012
-
Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response..
128.
2011
-
Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets..
128.
2011
-
Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities..
127.
2011
-
Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis..
125.
2010
-
Regional and racial disparities in asthma hospitalizations in Mississippi..
125.
2010
-
Voluntarily reported unintentional injections from epinephrine auto-injectors..
125.
2010
-
Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis..
124.
2009
-
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management..
124.
2009
-
Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes..
124.
2009
-
Mutation of tyrosine 145 of lymphocyte cytosolic protein 2 protects mice from anaphylaxis and arthritis..
124.
2009
-
Anaphylaxis in the community: learning from the survivors..
124.
2009
-
IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells..
123.
2009
-
Sesame Allergy: Role of Specific IgE and Skin Prick Testing in Predicting Food Challenge Results..
123.
2009
-
Improving asthma self-efficacy: developing and testing a pilot community-based asthma intervention for African American adults..
123.
2009
-
Quality of care for acute asthma in 63 US emergency departments..
123.
2008
-
Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs..
122.
2008
-
Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis..
121.
2008
-
Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes..
120.
2007
-
Regional differences in EpiPen prescriptions in the United States: the potential role of vitamin D..
120.
2007
-
Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis..
119.
2007
-
Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility..
118.
2006
-
Efficacy and safety of mometasone furoate nasal spray in nasal polyposis..
116.
2005
-
Multicenter study of emergency department visits for insect sting allergies..
116.
2005
-
Serum nutrient markers and skin prick testing using data from the Third National Health and Nutrition Examination Survey..
114.
2004
-
Multicenter study of emergency department visits for food allergies..
113.
2004
-
Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study..
106.
2000
-
Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma..
104.
1999
-
Chronic sinusitis: risk factors for extensive disease..
100.
1997
-
Nebulized salbutamol with and without ipratropium bromide in the treatment of acute asthma..
100.
1997
-
Decreased nasal goblet cells in patients reporting topical corticosteroid use..
99.
1997
-
Polymorphism in transporter antigen peptides gene (TAP1) associated with atopy in Tunisians..
99.
1997
-
A localized vaginal allergic response in women with recurrent vaginitis..
81.
1988
-
Hereditary angioedema: a decade of management with stanozolol..
80.
1987
-
IgE-mediated hypersensitivity in human heart tissue: histamine release and functional changes..
77.
1986
-
Underestimation of specific immunoglobulin E by microtiter plate enzyme-linked immunosorbent assays..
76.
1985
-
Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin..
72.
1983
-
Continuing medical education. This continuing medical education self-assessment program is sponsored by the American Academy of Allergy and Immunology and supported by a grant-in-aid from Fisons Corporation..
71.
1983
-
Reduction of interference by specific IgG with a modified microtiter solid-phase radioimmunoassay to measure honeybee venom IgE..
71.
1983
-
A quantitative enzyme-linked immunosorbent assay for honeybee venom-specific immunoglobulin G..
70.
1982
-
Clinical and biochemical effects of stanozolol therapy for hereditary angioedema..
68.
1981
-
Microtiter solid-phase radioimmunoassay for specific immunoglobulin E..
67.
1981
-
Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema..
64.
1979
-
Response to corticosteroids in chronic bronchitis..
62.
1978
-
Tranexamic acid: preoperative prophylactic therapy for patients with hereditary angioneurotic edema..
60.
1977
-
Reply..
138.
2016
-
Reply: To PMID 25748064..
136.
2015
-
Trends in pediatric emergency department visits for food-induced anaphylaxis..
126.
2010
-
Atopic dermatitis keratinocytes exhibit normal T(H)17 cytokine responses..
125.
2010
-
17q12-21 variants interact with smoke exposure as a risk factor for pediatric asthma but are equally associated with early-onset versus late-onset asthma in North Americans of European ancestry..
124.
2009
-
Analysis of insect-sting study..
96.
1995
-
Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations.
2023
-
Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations.
2018
-
Alveolar eosinophilia in current smokers with chronic obstructive pulmonary disease in the SPIROMICS cohort.
2017
-
Atopic dermatitis endotypes and implications for targeted therapeutics.
2019
-
Psoriasis pathogenesis and the development of novel targeted immune therapies.
2017
-
Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march.
2017
-
Basophils and allergic inflammation.
2013
-
Proximal signaling events in Fc epsilon RI-mediated mast cell activation.
2007
-
Mechanisms of nutrient modulation of the immune response.
2005
-
21. Immunohematologic disorders.
2003
-
Epithelial-neuronal-immune cell interactions: implications for immunity, inflammation, and tissue homeostasis at mucosal sites.
2024
-
Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases.
2023
-
Chronic obstructive pulmonary disease subpopulations and phenotyping.
2018
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)